These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 222523

  • 1. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
    Lum CT, Sutherland DE, Najarian JS.
    Clin Immunol Immunopathol; 1979 Apr; 12(4):453-9. PubMed ID: 222523
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
    Plunkett W, Alexander L, Chubb S, Loo TL.
    Biochem Pharmacol; 1979 Apr; 28(2):201-6. PubMed ID: 426835
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
    Svendsen KR, Overgaard-Hansen K, Frederiksen S.
    Cancer Chemother Pharmacol; 1988 Apr; 21(1):35-9. PubMed ID: 3257721
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adenosine deaminase inhibitors enhance cerebral anoxic hyperemia in the rat.
    Phillis JW, DeLong RE, Towner JK.
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):295-9. PubMed ID: 3872875
    [Abstract] [Full Text] [Related]

  • 7. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP.
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract] [Full Text] [Related]

  • 8. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
    Wolberg G, Zimmerman TP.
    Ann N Y Acad Sci; 1985 Feb; 451():215-26. PubMed ID: 3878118
    [Abstract] [Full Text] [Related]

  • 9. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM, Belch A, Henderson JF.
    Biochem Pharmacol; 1980 Apr 15; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance.
    Dhasmana JP, Digerness SB, Geckle JM, Ng TC, Glickson JD, Blackstone EH.
    J Cardiovasc Pharmacol; 1983 Apr 15; 5(6):1040-7. PubMed ID: 6196552
    [Abstract] [Full Text] [Related]

  • 12. Enzyme inhibition titration assay for 2'-deoxycoformycin and its application to the study of the relationship between drug concentration and tissue adenosine deaminase in dogs and rats.
    Chassin MM, Adamson RH, Zaharevitz DW, Johns DG.
    Biochem Pharmacol; 1979 Jun 15; 28(12):1849-55. PubMed ID: 454456
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.
    Bessodes M, Bastian G, Abushanab E, Panzica RP, Berman SF, Marcaccio EJ, Chen SF, Stoeckler JD, Parks RE.
    Biochem Pharmacol; 1982 Mar 01; 31(5):879-82. PubMed ID: 7082355
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of human T-cell rosette formation by the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT, Schmidtke JR, Sutherland DE, Najarian JS.
    Clin Immunol Immunopathol; 1978 Jul 01; 10(3):258-61. PubMed ID: 307473
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA, Thuillier L, Hamet M, Garreau F, Moncion A, Pérignon JL.
    Clin Chim Acta; 1986 Apr 15; 156(1):61-9. PubMed ID: 3486057
    [Abstract] [Full Text] [Related]

  • 20. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE, Dawicki DD, Agarwal KC, Chen SF, Stoeckler JD.
    Ann N Y Acad Sci; 1985 Apr 15; 451():188-203. PubMed ID: 3878117
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.